Affinity Capture
Affinity Capture - Related Videos
10:37
Protein Complex Affinity Capture from Cryomilled Mammalian Cells
0 Views •
Cited by 37 •
2016
Here we describe protocols to disrupt mammalian cells by solid-state milling at a cryogenic temperature, produce a cell extract from the resulting cell powder, and isolate protein complexes of interest by affinity capture upon antibody-coupled micron-scale paramagnetic beads.
08:10
A Liquid Phase Affinity Capture Assay Using Magnetic Beads to Study Protein-Protein Interaction: The Poliovirus-Nanobody Example
0 Views •
Cited by 3 •
2012
In this article, a simple, quantitative, liquid phase affinity capture assay is presented. It is a reliable technique based on the interaction between magnetic beads and tagged proteins (e.g. nanobodies) on one hand and the affinity between the tagged protein and a second, labeled protein (e.g. poliovirus) on the other.
03:07
Electron Affinity
0 Views •
2020
The electron affinity (EA) is the energy change for adding an electron to a gaseous atom to form an anion (negative ion). This process can be either endothermic or exothermic, depending on the element. Many of these elements have negative values of EA, which means that energy is released when the gaseous atom accepts an electron. However, for some elements, energy is required for the atom to become negatively charged, and the value of their EA is positive. Just as with ionization energy,...
01:41
Affinity and Avidity
0 Views •
2019
Overview Antibodies bind to toxins or substances on the surface of cells, bacteria, viruses, or fungi. The substance is called an antigen, and the precise binding site is the epitope. The strength of the antibody-epitope interaction is called affinity. When an antibody binds an antigen by multiple epitopes, the cumulative strength of the interaction is called avidity. The strength of the interaction influences the elicited immune response. The Adaptive Immune System Increases Efficiency by...
07:53
Activated Cross-linked Agarose for the Rapid Development of Affinity Chromatography Resins - Antibody Capture as a Case Study
0 Views •
Cited by 8 •
2019
In this procedure, a DsRed-based epitope ligand is immobilized to produce a highly selective affinity resin for the capture of monoclonal antibodies from crude plant extracts or cell culture supernatants, as an alternative to Protein A.
FAQs
Retention depends on the compatibility between the target and the immobilized affinity ligand or binding partner. Under the selected binding conditions, the target forms a reversible interaction with that matrix, whereas other mixture components are not retained to the same extent. This differential binding allows affinity capture to isolate a biomolecule from a complex sample.
Reversibility makes the captured material recoverable rather than permanently attached to the matrix. After contaminants are removed, changing pH or salt, or introducing a competing ligand, releases the target from its binding partner. These variables serve as controlled elution triggers, linking the chemical environment to recovery of the purified biomolecule.
Affinity capture can reduce downstream processing because the binding step provides selectivity early in purification. By retaining the desired biomolecule while contaminants are washed away, it decreases the complexity of material entering later operations. This is useful when bioengineered products must progress from a complex mixture toward analytical characterization or manufacturing.
An effective setup requires a complex sample, a matrix carrying the appropriate immobilized ligand or binding partner, and defined conditions for binding and release. The workflow also needs a washing stage to remove contaminants without losing the retained target. Adjustments to pH, salt, or a competing ligand then enable controlled recovery.
Bioengineering applications include purification of recombinant proteins, antibodies, and other engineered biomolecules. The method is particularly relevant when a product must be separated selectively from a complex mixture rather than processed through less targeted steps. Its binding-based selectivity can help prepare these biomolecules for subsequent characterization or biomanufacturing workflows.
The technique produces a selectively isolated biomolecule, which supports analytical characterization by reducing the presence of unwanted mixture components. The same principle also fits scalable biomanufacturing, where selective purification can simplify downstream processing. Thus, one capture strategy can serve both research-oriented analysis and production workflows for engineered biomolecules.